Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States (vol 6, 100252, 2021)ESMO OPENIF8.32021-12-011OAAI
Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United StatesESMO OPENIF8.32021-10-0136OAAI
INCIDENCE AND RISK FACTORS FOR STROKE ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITOR THERAPY IN CANCER PATIENTS USING REAL-WORLD CLINICAL DATAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-11-091PREAI
Role of immune-checkpoint inhibitors in lung cancer免疫检查点抑制剂在肺癌中的作用therapeutic advances in musculoskeletal diseaseIF32018-01-31100OAAI
Anal Cancer (AC): Chemotherapy treatment trends over time from 1989 to 2010 at the Ottawa Hospital Cancer Centre, Ottawa, CanadaEUROPEAN JOURNAL OF CANCERIF7.12015-09-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向